General

One of the most well-known hedge fund managers on Wall Street, Greenlight Capital’s David Einhorn, has hit a rough patch with his investing over the past several years. Einhorn made his reputation by correctly predicting some high-profile market downfalls and delivering a 26-percent average...

The odds of running a $1 billion business are slim to none. Unless you’re Elon Musk. Then you run a few. The CEO of Tesla Inc (NASDAQ: TSLA), SpaceX and the Boring Co. is now known to head two firms that are both valued north of $25 billion. With Tesla’s $46-billion market cap and...

The White House informed lawmakers Friday it has reached a deal to put the Chinese telecom company ZTE back in business, according to a New York Times report. Since April 16, ZTE has been banned from purchasing components from American firms for seven years. The denial order — issued as...

The iShares MSCI Malaysia ETF (NYSE: EWM) is experiencing an eventful May. EWM, the lone U.S.-listed exchange traded fund tracking Malaysian stocks, sank after a surprise election result ended the 61-year reign of Prime Minister Najib Razak’s ruling coalition. Razak was a controversial figure...

Novartis (NYSE: NVS) announced that its generic arm, Sandoz, obtained approval for Zessly, a biosimilar version of Johnson & Johnson (NYSE: JNJ)'s Remicade, in Europe. Zessly is approved for use in all indications of the branded drug including rheumatoid arthritis, adult Crohn's...

Emerging markets stocks have recently taken their lumps, but Brazilian equities have been among the worst offenders.   On Friday, the MSCI Brazil 25/50 Index was sporting a second-quarter loss of 13 percent, and that Brazilian benchmark was spotted more than 17 percent below its 52-week high,...

A few weeks ago, Benzinga had the chance to visit the offices of Poseidon Asset Management, a San Francisco-based cannabis-focused long/short hedge fund with more than $40 million in assets under management. Co-founder and managing partner Emily Paxhia mentioned and her brother and partner...

Today, Stacey Cunningham becomes the first female president of the New York Stock Exchange and the second woman, just behind Nasdaq’s Adena Friedman, to head a major U.S. exchange. The industry, the media and even Intercontinental Exchange call Cunningham’s ascension a feat for women...

The market continues to be a chop fest, but I’ve continued to find enough success to keep my accuracy above 70 percent and remain within spitting distance of my unofficial goal of making May a $100k month. However, one of the biggest obstacles I’ve come against, apart from the erratic...

Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened? On this day 87 years ago, the New York Stock Exchange began regularly reporting short selling data for the first time. Where The Market Was The Dow finished the day at 132.87. The...

Casual restaurant chain Zoe's Kitchen Inc (NYSE: ZOES) reported first-quarter results Thursday that made it clear the growth story "is broken for now," according to Maxim Group.  The Analyst  Maxim Group's Stephen Anderson downgraded Zoe's Kitchen from...

Owning a home has a lot of benefits—like being able to remodel the kitchen, landscaping your backyard to create a dream oasis, or painting the walls your favorite color of blue—but there is one drawback: having to pay for home improvements yourself. When you are a renter, you can just...

Herbalife Nutrition Ltd (NYSE: HLF) fell as much as 7.4 percent Friday after the firm’s largest shareholder pared its six-year long position and third-oldest asset. Icahn Enterprises LP Common Stock (NASDAQ: IEP) submitted 11.4 million of its shares into Herbalife’s self-tender offer....

Shares of VistaGen Therapeutics Inc (NASDAQ: VTGN) rocketed up over 40 percent to $1.36 in after-hours trading on Thursday — a mere fraction of the 500 percent upside implied by a late-day note from Oppenheimer. The Analyst Oppenheimer’s Jay Olson initiated coverage on VistaGen with...

Inogen Inc (NASDAQ: INGN) dropped more than $10 per share Thursday morning as a pair of analysts butted heads over the stock. Citron Research’s Andrew Left published a new report on Inogen in which he said Inogen is facing the prospect of stiff competition and doing so with undifferentiated...